- Skin and soft tissue infections
- Abdominal infections
TIGIMAX
| MRP | : |
|
| Price | : | ₹920.00 |
| You Save | : | ₹4,776.55 (83.85%) |
1 Vial(s)
Tigimax 50mg injection is an antibiotic belonging to the tetracycline class, with Tigecycline as its active ingredient. It is primarily used to treat severe bacterial infections affecting the skin and abdomen. This medication is not advised for children younger than eight years old. Tigimax is generally reserved for cases where other antibiotics are deemed unsuitable or ineffective for specific infections.
This medication is contraindicated for individuals who have known hypersensitivity or allergic reactions to other antibiotics in the tetracycline class, such as minocycline or doxycycline. Prior to receiving this injection, it is essential to discuss your medical history and any current medications with your healthcare provider. Important considerations include poor wound healing, diarrhea, liver issues, cholestasis (a blockage of the bile ducts), or the use of anticoagulants (medications that prevent excessive blood clotting). Your healthcare provider must be informed of these conditions or medications to assess whether Tigimax 50mg injection is appropriate for you or if any modifications to your treatment plan are necessary.
If you experience diarrhea before starting treatment with Tigimax 50mg injection, or if you develop diarrhea during or after the treatment, it is crucial to inform your doctor immediately. Avoid taking any medication for diarrhea without first consulting your physician. This drug is not safe for use in pregnant women as it may pose risks to the fetus. Notify your healthcare provider if you are pregnant, suspect you might be pregnant, or are planning to become pregnant. It is unclear whether this medication is excreted in breast milk, so please consult your doctor before breastfeeding.
